Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC).
Despite huge advances in the fight against HIV concerning diagnosis, clinical efficacy of antiretroviral treatments (ART), patient survival and quality of life, there is still no cure. Recent developments in HIV cure research have opened the way for clinical trials which could lead to a temporary or...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5667862?pdf=render |
id |
doaj-df1109da308c4d23bab5a6f52eefae10 |
---|---|
record_format |
Article |
spelling |
doaj-df1109da308c4d23bab5a6f52eefae102020-11-25T01:10:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011211e018748910.1371/journal.pone.0187489Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC).Christel ProtièreBruno SpireMarion MoraIsabelle Poizot-MartinMarie PréauMarjolaine DoumerguePhilippe MorlatDavid ZucmanCécile GoujardFrançois RaffiOlivier LambotteMarie Suzan-MontiDespite huge advances in the fight against HIV concerning diagnosis, clinical efficacy of antiretroviral treatments (ART), patient survival and quality of life, there is still no cure. Recent developments in HIV cure research have opened the way for clinical trials which could lead to a temporary or definitive end to ART. However, ethical questions exist about related trial-participation risks. The main goal of the ANRS-APSEC survey was, using Q-methodology, to investigate the viewpoints of people living with HIV (PLWH) and HIV healthcare providers (HHP) regarding motivations for and barriers to participation in HIV Cure-related clinical trials (HCRCT).Thirty-three statements were defined encompassing seven dimensions: treatment and follow-up; risks; benefits; patient-physician relationship; beliefs and attitudes; information; target population. Forty-one PLWH and 41 HHP from five French HIV services were asked to rank-order the statements.Five main viewpoints were elicited from "the most motivated" to "the most reluctant" vis-à-vis HCRCT participation. All placed importance on the wish to participate in HIV research. This result is in line with the HIV-specific culture of joint mobilization. For some viewpoints, the motivation to participate in/propose HCRCT was primarily conditioned by side-effects and/or by constraints, which overall were more accepted by PLWH than HHP. Some viewpoints placed particular importance on HCRCT recruitment strategies. Finally, some expressed a high acceptance of risks and constraints but emphasized the need for information.HIV cure research clinical trials (HCRCT) constitute a risky yet unavoidable step towards the goal of finding a cure. To improve future HCRCT and informed consent designs, based on PLWH and HHP preferences and expectations, we need greater knowledge about how these populations perceive the risks and the benefits of HCRCT. Our results confirmed the importance of careful, studied HCRCT design, management and communication, to ensure PLWH and HHP acceptability and convergence of their expectations.http://europepmc.org/articles/PMC5667862?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Christel Protière Bruno Spire Marion Mora Isabelle Poizot-Martin Marie Préau Marjolaine Doumergue Philippe Morlat David Zucman Cécile Goujard François Raffi Olivier Lambotte Marie Suzan-Monti |
spellingShingle |
Christel Protière Bruno Spire Marion Mora Isabelle Poizot-Martin Marie Préau Marjolaine Doumergue Philippe Morlat David Zucman Cécile Goujard François Raffi Olivier Lambotte Marie Suzan-Monti Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC). PLoS ONE |
author_facet |
Christel Protière Bruno Spire Marion Mora Isabelle Poizot-Martin Marie Préau Marjolaine Doumergue Philippe Morlat David Zucman Cécile Goujard François Raffi Olivier Lambotte Marie Suzan-Monti |
author_sort |
Christel Protière |
title |
Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC). |
title_short |
Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC). |
title_full |
Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC). |
title_fullStr |
Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC). |
title_full_unstemmed |
Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC). |
title_sort |
patterns of patient and healthcare provider viewpoints regarding participation in hiv cure-related clinical trials. findings from a multicentre french survey using q methodology (anrs-apsec). |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2017-01-01 |
description |
Despite huge advances in the fight against HIV concerning diagnosis, clinical efficacy of antiretroviral treatments (ART), patient survival and quality of life, there is still no cure. Recent developments in HIV cure research have opened the way for clinical trials which could lead to a temporary or definitive end to ART. However, ethical questions exist about related trial-participation risks. The main goal of the ANRS-APSEC survey was, using Q-methodology, to investigate the viewpoints of people living with HIV (PLWH) and HIV healthcare providers (HHP) regarding motivations for and barriers to participation in HIV Cure-related clinical trials (HCRCT).Thirty-three statements were defined encompassing seven dimensions: treatment and follow-up; risks; benefits; patient-physician relationship; beliefs and attitudes; information; target population. Forty-one PLWH and 41 HHP from five French HIV services were asked to rank-order the statements.Five main viewpoints were elicited from "the most motivated" to "the most reluctant" vis-à-vis HCRCT participation. All placed importance on the wish to participate in HIV research. This result is in line with the HIV-specific culture of joint mobilization. For some viewpoints, the motivation to participate in/propose HCRCT was primarily conditioned by side-effects and/or by constraints, which overall were more accepted by PLWH than HHP. Some viewpoints placed particular importance on HCRCT recruitment strategies. Finally, some expressed a high acceptance of risks and constraints but emphasized the need for information.HIV cure research clinical trials (HCRCT) constitute a risky yet unavoidable step towards the goal of finding a cure. To improve future HCRCT and informed consent designs, based on PLWH and HHP preferences and expectations, we need greater knowledge about how these populations perceive the risks and the benefits of HCRCT. Our results confirmed the importance of careful, studied HCRCT design, management and communication, to ensure PLWH and HHP acceptability and convergence of their expectations. |
url |
http://europepmc.org/articles/PMC5667862?pdf=render |
work_keys_str_mv |
AT christelprotiere patternsofpatientandhealthcareproviderviewpointsregardingparticipationinhivcurerelatedclinicaltrialsfindingsfromamulticentrefrenchsurveyusingqmethodologyanrsapsec AT brunospire patternsofpatientandhealthcareproviderviewpointsregardingparticipationinhivcurerelatedclinicaltrialsfindingsfromamulticentrefrenchsurveyusingqmethodologyanrsapsec AT marionmora patternsofpatientandhealthcareproviderviewpointsregardingparticipationinhivcurerelatedclinicaltrialsfindingsfromamulticentrefrenchsurveyusingqmethodologyanrsapsec AT isabellepoizotmartin patternsofpatientandhealthcareproviderviewpointsregardingparticipationinhivcurerelatedclinicaltrialsfindingsfromamulticentrefrenchsurveyusingqmethodologyanrsapsec AT mariepreau patternsofpatientandhealthcareproviderviewpointsregardingparticipationinhivcurerelatedclinicaltrialsfindingsfromamulticentrefrenchsurveyusingqmethodologyanrsapsec AT marjolainedoumergue patternsofpatientandhealthcareproviderviewpointsregardingparticipationinhivcurerelatedclinicaltrialsfindingsfromamulticentrefrenchsurveyusingqmethodologyanrsapsec AT philippemorlat patternsofpatientandhealthcareproviderviewpointsregardingparticipationinhivcurerelatedclinicaltrialsfindingsfromamulticentrefrenchsurveyusingqmethodologyanrsapsec AT davidzucman patternsofpatientandhealthcareproviderviewpointsregardingparticipationinhivcurerelatedclinicaltrialsfindingsfromamulticentrefrenchsurveyusingqmethodologyanrsapsec AT cecilegoujard patternsofpatientandhealthcareproviderviewpointsregardingparticipationinhivcurerelatedclinicaltrialsfindingsfromamulticentrefrenchsurveyusingqmethodologyanrsapsec AT francoisraffi patternsofpatientandhealthcareproviderviewpointsregardingparticipationinhivcurerelatedclinicaltrialsfindingsfromamulticentrefrenchsurveyusingqmethodologyanrsapsec AT olivierlambotte patternsofpatientandhealthcareproviderviewpointsregardingparticipationinhivcurerelatedclinicaltrialsfindingsfromamulticentrefrenchsurveyusingqmethodologyanrsapsec AT mariesuzanmonti patternsofpatientandhealthcareproviderviewpointsregardingparticipationinhivcurerelatedclinicaltrialsfindingsfromamulticentrefrenchsurveyusingqmethodologyanrsapsec |
_version_ |
1725173380279173120 |